Division of Pediatric Surgery, Children's Hospital Los Angeles, CA; Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA.
Division of Pediatric Hospital Medicine, Children's Hospital Los Angeles; Department of Pediatrics, Keck School of Medicine of the University of Southern California.
Surgery. 2020 Nov;168(5):942-947. doi: 10.1016/j.surg.2020.04.060. Epub 2020 Jul 9.
The impact of postoperative opioid use on outcomes for children with perforated appendicitis is unknown.
A retrospective cohort study was performed using the Pediatric Health Information System database from 2005 to 2015. Children 2 to 18 years with perforated appendicitis who underwent an appendectomy were identified. Postoperative day analgesic use was categorized as nonopioid analgesia alone, opioids (with or without nonopioid analgesia), or no analgesics. The impact of postoperative opioid use on postoperative duration of stay and 30-day readmission was evaluated using multivariable mixed-effects regression analysis.
Overall, 47,726 children with perforated appendicitis were identified. On postoperative day 1, 17.7% received nonopioid analgesia alone, 77.6% received opioids, and 4.7% received no analgesics. On adjusted analysis, postoperative day 1 opioid use was associated with a 0.75-day (95% confidence interval: 0.54-0.96) increased postoperative duration of stay. Starting opioids after postoperative day 1 was associated with 2.21 days (95% confidence interval: 1.90-2.51) longer postoperative duration of stay. Among children who received opioids on postoperative day 1, continued use of opioids after postoperative day 1 was associated with a 1.88 day (95% confidence interval: 1.77-1.98) longer postoperative duration of stay. Postoperative day 1 opioid use did not significantly affect 30-day readmission.
Early and continued postoperative opioid use is associated with prolonged postoperative duration of stay in children undergoing appendectomy for perforated appendicitis. Minimizing opioid use, even on postoperative day 2, may result in a decreased postoperative duration of stay.
术后使用阿片类药物对穿孔性阑尾炎患儿结局的影响尚不清楚。
采用 2005 年至 2015 年期间的小儿健康信息系统数据库进行回顾性队列研究。筛选出接受阑尾切除术的 2 至 18 岁穿孔性阑尾炎患儿。术后第 1 天,将术后镇痛药物使用情况分为单独使用非阿片类镇痛药、使用阿片类药物(无论是否使用非阿片类镇痛药)或不使用镇痛药物。采用多变量混合效应回归分析评估术后使用阿片类药物对术后住院时间和 30 天再入院的影响。
总体而言,共纳入 47726 例穿孔性阑尾炎患儿。术后第 1 天,17.7%的患儿单独使用非阿片类镇痛药,77.6%的患儿使用阿片类药物,4.7%的患儿未使用镇痛药物。调整分析后,术后第 1 天使用阿片类药物与术后住院时间延长 0.75 天(95%置信区间:0.54-0.96)相关。术后第 1 天以后开始使用阿片类药物与术后住院时间延长 2.21 天(95%置信区间:1.90-2.51)相关。在术后第 1 天使用阿片类药物的患儿中,术后第 1 天以后继续使用阿片类药物与术后住院时间延长 1.88 天(95%置信区间:1.77-1.98)相关。术后第 1 天使用阿片类药物与 30 天再入院无关。
在接受阑尾切除术治疗穿孔性阑尾炎的患儿中,早期和持续使用术后阿片类药物与术后住院时间延长相关。即使在术后第 2 天,减少阿片类药物的使用量也可能会缩短术后住院时间。